Liquid agricultural formulations containing PPO inhibitors

By combining solvents/emulsifiers and using organic acids, the stability issues of PPO inhibitor herbicide formulations have been resolved, achieving high loading capacity, good storage and dilution stability, and ensuring the bioavailability and environmental friendliness of the herbicide.

CN121174940APending Publication Date: 2025-12-19BASF AGRO BV
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202480034118.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-24
Filing Date
2024-05-23
Publication Date
2025-12-19

AI Technical Summary

Technical Problem

Existing technologies struggle to provide stable PPO inhibitor herbicide formulations, especially for pyrimethanil and trifluralin, which suffer from insufficient chemical and physical stability and poor dilution stability, leading to inconsistent bioefficacy and environmental risks.

Method used

Formulated using a combination of solvents/emulsifiers and organic acids, including water, water-miscible organic solvents, specific emulsifiers, and fatty acid alkyl esters, to form stable liquid formulations that ensure chemical and physical stability as well as high dilution stability.

Benefits of technology

This achieves high loading capacity, good storage stability, and dilution stability of PPO inhibitor herbicides, ensuring uniformity and bioavailability of the spray solution and reducing environmental risks.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
  • Figure SMS_4
    Figure SMS_4
Patent Text Reader

Abstract

The present invention relates to a liquid agricultural formulation containing at least one herbicide, in particular selected from the group of protoporphyrinogen-IX-oxidase inhibitors (PPO inhibitors) of saflufenacil and triaziflam, and a solvent-emulsifier combination. The invention also relates to a method for preparing a liquid agricultural formulation of at least one herbicide containing a group of protoporphyrinogen-IX-oxidase inhibitors. Furthermore, the present invention relates to the use of said liquid formulation for controlling the growth of undesired plants and to a method for controlling the growth of undesired plants comprising applying said formulation to an undesired plant, to a part of an undesired plant or to an area where an undesired plant grows or is likely to grow.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This invention relates to a liquid agricultural formulation containing at least one herbicide, specifically selected from the group consisting of protoporphyrinogen-IX-oxidase inhibitors (PPO inhibitors) such as pyrimethanil and trifluralin, and a solvent-emulsifier combination. The invention also relates to a method for preparing a liquid agricultural formulation containing at least one herbicide from the group consisting of protoporphyrinogen-IX-oxidase inhibitors. Furthermore, the invention relates to the use of said liquid formulation for controlling unwanted plant growth. Background Technology

[0002] Some organic agrochemical pesticide compounds, such as herbicides, fungicides, insecticides—or general pesticides—are typically applied in the form of diluted aqueous compositions to achieve good interaction with target organisms, which can be weeds, fungi, or pests like invertebrates. While some of these agrochemical pesticides are water-soluble, a significant number of organic pesticide compounds are only slightly soluble in water or even insoluble in water. In particular, herbicides in the PPO inhibitor group, especially pyrimethanil and trifluralin, are only slightly soluble in a variety of liquid media, particularly aqueous media. Therefore, providing stable liquid formulations containing PPO inhibitors, especially pyrimethanil or trifluralin, is extremely challenging.

[0003] Organic herbicides with limited solubility in water are often formulated as wettable powders or granules, emulsifiable concentrates (EC), water-dispersible granules (WDG), or aqueous suspension concentrates (SC). Such formulations of insoluble or slightly water-soluble herbicides are typically diluted with water to a predetermined concentration for field application and are usually produced in the form of spray solutions.

[0004] Suspension concentrates are formulations in which the active ingredient exists as finely dispersed solid particles suspended in an aqueous dispersion medium by surfactants, such as wetting agents, dispersants, and rheological or suspending agents, to stabilize the active ingredient particles in the dispersion medium. However, SCs often encounter problems due to sedimentation during long-term or high-temperature storage, the tolerance of sedimented particles to resuspension, and the formation of crystalline material during storage. Therefore, formulations are difficult to handle, and their bioavailability can be inconsistent, which is particularly problematic for highly active modern herbicides. Furthermore, SCs are limited to active substances with relatively high melting points. Most agrochemicals are only slightly water-soluble, and when formulated as aqueous SCs, they become partially "inactivated" by water.

[0005] In wettable powders or granules, herbicide compounds exist in granular form. When wettable powders or granules are diluted in water for field application, the granules must disintegrate in the water to achieve a uniform distribution of the herbicide compound in the aqueous dilution. Unfortunately, if the solid formulation has been stored for an extended period or in an opened package, granule disintegration is often hindered. Restricted disintegration can lead to inconsistent bioefficacy.

[0006] Emulsifiable concentrates are non-aqueous liquid formulations in which herbicide compounds are dissolved in a mixture of non-polar organic solvents and emulsifiers. Upon dilution with water, an oil-in-water emulsion is formed. Unfortunately, emulsifiable concentrates tend to be unstable after storage because surfactants and solvents may undergo phase separation. Therefore, emulsification in water may be hindered, which could again lead to inconsistent bioefficacy. Furthermore, from a workplace hygiene, environmental safety, and health protection perspective, large amounts of non-polar solvents may be undesirable.

[0007] WO 2011 / 023759 describes an aqueous suspension concentrate formulation for plant protection, comprising phenylsulfuron-methyl in its anhydrous crystalline form; at least one nonionic surfactant selected from polyoxyethylene-polyoxy-C3-C4-alkylene block copolymers; at least one anionic surfactant comprising at least one aryl sulfonate group; and water; wherein the pH of the formulation is in the range of 3 to 7.

[0008] WO 2011 / 070051 describes a liquid suspension concentrate formulation for plant protection, comprising pyrimisulfuron in crystalline anhydrous form; at least one diluent selected from: a hydrocarbon solvent having a boiling point of at least 100°C; and C8-C... 26 - C1-C8-alkyl esters of fatty acids, C8-C 26 - Mono- and di-C1-C4-alkylamides of fatty acids; at least two different nonionic surfactants selected from the following: C3-C 20 - Poly-ethoxylated alkanols - co-C3-C4-alkoxylated, C8-C 22 - Polyethoxylated alkanols, polyester-polyoxyethylene block copolymers, polyethoxylated mono-, di-, or tristyrylphenols, and polyethoxylated vegetable oils; and at least one C1-C 16 -Anionic surfactants of alkyl aromatic sulfonates.

[0009] Aqueous multiphase formulations (in which the herbicide compound is dissolved in the organic phase, such as microemulsions (also known as ME formulations) or even liquid homogenized formulations) can, in principle, avoid some of the disadvantages mentioned above.

[0010] WO 2021 / 038439 describes a soluble liquid (SL) composition comprising bensulfuron and an organic base, and the use of an amine salt of bensulfuron in the preparation of the soluble liquid composition. In this SL formulation, bensulfuron is anhydrous and soluble in the organic base, and the SL formulation is in a non-aqueous medium. Compared to aqueous suspension concentrate (SC) formulations of bensulfuron, the SL formulation of bensulfuron is significantly more potent and effective against weeds.

[0011] However, the development of such formulations (e.g., stable suspensions, microemulsions, emulsion concentrates, and liquid homogenized formulations) for herbicides in the PPO inhibitor group, particularly pyrimethanil, has been a long-standing challenge. In particular, the stability of these formulations for herbicides in the PPO inhibitor group is not always satisfactory, and unmixing (separation) or crystallization of the herbicide can occur. Furthermore, the dilution stability of these formulations is sometimes insufficient, as the PPO inhibitor group herbicides are only slightly water-soluble and therefore tend to separate upon or after dilution with water, especially when the formulation is highly loaded with the PPO inhibitor group herbicide. Another issue is that certain types of solvents providing stable formulations can be problematic given environmental requirements and workplace hygiene. Summary of the Invention

[0012] Liquid formulations of PPO inhibitors, particularly those containing pyrimethanil or trifluralin, are in high demand and provide sufficient chemical and physical stability to allow for high loadings of these biocides. Furthermore, formulations should exhibit high dilution stability, meaning that upon dilution with water, they form stable emulsions or dispersions of the PPO inhibitor without forming deposits or creams.

[0013] Therefore, the object of the present invention is to provide a stable herbicide formulation of at least one herbicide from the group of PPO inhibitors, particularly pyrimethanil and / or trifluralin. Such herbicide formulations should exhibit both chemical and physical stability, especially good storage stability and high dilution stability.

[0014] Surprisingly, it has now been found that liquid formulations containing at least one herbicide from the group consisting of a solvent / emulsifier combination as defined herein and optionally, at least one PPO inhibitor having a pKA of an organic acid in the range of 1 to 6, particularly 2 to 5, exhibit excellent stability, especially outstanding chemical and physical stability and dilution stability. In particular, the liquid formulations according to the invention show low degradation of the herbicide components contained in the formulation. Furthermore, the liquid formulations have high bioavailability and a high loading of herbicidal active ingredients. The liquid formulations of the invention exhibit good dilution stability, and the aqueous diluents remain stable in diluted form, and therefore, they are easy for users to handle and apply.

[0015] Therefore, the present invention relates to a liquid formulation comprising...

[0016] a) At least one herbicide belonging to the group consisting of PPO inhibitors as component A),

[0017] b) Optionally, at least one organic acid having a pKA value in the range of 1 to 6, particularly in the range of 3 to 5, as component B).

[0018] c) The solvent-emulsifier combination as component C), which contains

[0019] c1) Water as component C1),

[0020] c2) is at least one water-miscible organic solvent as component C2).

[0021] c3) is at least one first emulsifier of component C3), selected from the group consisting of: C6-C 25 -Alkyl alcohol alkoxylates, C6-C 25 - Alkenol alkoxylates and mixtures thereof

[0022] c4) as at least one second emulsifier of component C4), selected from the group consisting of arylphenol ethoxylates, particularly selected from stilbene phenol ethoxylates, tristilbene phenol ethoxylates and mixtures thereof, and

[0023] c5) as at least one C6-C of component C5) 20 -Fatty acid-C1-C4-alkyl esters, especially at least one C6-C5 component) 20 - Fatty acid methyl esters or ethyl esters

[0024] In a particular embodiment, component C5) comprises at least one C 18 -Fatty acid-C1-C4-alkyl ester;

[0025] Furthermore, in another specific embodiment, component C5) is C6-C 10 -Fatty acid-C1-C4-alkyl esters, which preferably contain at least one C8-C4 alkyl ester. 10 - Fatty acid - C1-C4-alkyl ester.

[0026] Furthermore, the present invention also relates to a method for preparing a liquid formulation as defined herein, the method comprising mixing components A), C), and (if component B) is included in the formulation) and B) (otherwise, of course, only A) and C) are mixed).

[0027] Another aspect of the invention relates to the use of liquid formulations as defined herein for controlling unwanted plant growth.

[0028] Furthermore, another aspect of the invention relates to a method for controlling the growth of unwanted plants, the method comprising the step of applying a preparation as defined herein to the unwanted plant, to a portion of the unwanted plant, or to an area where the unwanted plant is growing or may grow.

[0029] The liquid formulations according to the present invention have several advantages. In particular, they exhibit excellent dilution stability and good storage stability in both chemical and physical terms. Specifically, the liquid formulations of the present invention are stable against phase separation after storage and do not show degradation of PPO inhibitors when stored at high temperatures. Furthermore, the liquid formulations of the present invention exhibit good dilution stability, and the aqueous diluents remain stable in diluted form, thus making them easy for users to handle and administer. Detailed Implementation

[0030] As used herein, "herbicide" means one or more reagents, compounds and / or compositions that have herbicidal and / or herbicidal activity.

[0031] As used herein, the terms “control” and “counter” are synonyms, referring to the undesirable inhibition, control, reduction, or complete destruction of plant growth. Preferably, the growth of one or more harmful plants is substantially reduced (60%-79%), more preferably, the growth of one or more harmful plants is largely or completely inhibited (80%-100%), and particularly, the growth of one or more harmful plants is almost completely or completely inhibited (90%-100%).

[0032] As used herein, the terms “undesirable vegetation,” “undesirable species,” “undesirable plants,” “harmful plants,” “undesirable weeds,” “native plants,” or “harmful weeds” are used synonymously.

[0033] As used in this article, "post-emergence" refers to herbicide treatment applied to areas where weeds have already germinated and emerged from the ground or growing medium.

[0034] As used in this article, "de-germination" refers to the use of herbicides to reduce the presence of weeds during treatment. De-germination is typically used in minimally tilled or no-till fields because weeds cannot be controlled by tilling the soil. De-germination can be applied after harvest and / or before crop emergence. De-germination is particularly useful for weeds that appear between growing seasons.

[0035] Generally, unless otherwise explicitly stated, a term referred to in its plural form means that only the singular term applies.

[0036] In the context of this invention, the term "liquid formulation" refers to a formulation that is liquid at least under ambient conditions, i.e., at 20°C and 1013 mbar, particularly at 0°C or higher. Specifically, a liquid formulation should be understood as having a liquid content of 100 s at 20°C. -1 Formulations with dynamic viscosities determined at shear rates of up to 2000 mPa·s, particularly up to 1000 mPa·s, and typically in the range of 20 to 2000 mPa·s.

[0037] The formulations of the present invention are nearly homogeneous. The term "homogeneous" should be understood to mean that all non-liquid components of the formulation, particularly the PPO inhibitor herbicide, are dissolved in the liquid phase of the formulation at 20°C and 1013 mbar, or at least form a stable colloidal solution in the solvent / emulsifier composition that forms the fluid phase of the formulation. In particular, the formulations are characterized by having an immeasurable particle size or a particle size of at most 50 nm, as determined by light scattering at temperatures in the range of 20°C to 25°C. In particular, the formulations are nearly transparent or translucent, i.e., the turbidity of the formulation (expressed as transmittance (LD100 value), as determined by photometry using a 1 cm cuvette) is at least 10%, preferably at least 50%, and more preferably at least 70%.

[0038] The liquid formulation according to the invention exhibits good dilution stability. Dilution stability means that the liquid formulation forms a stable emulsion or dispersion of the biocidal agent when diluted in water, without precipitation or flocculation. Therefore, dilution stability ensures that the spray solution obtained by diluting the formulation with water will not clog the nozzle. Dilution stability can be assessed by diluting the liquid formulation with standard water at 30°C in a graduated cylinder to the desired concentration. After 30 minutes of dilution, the appearance of any separation or sediment is evaluated. The formulation is then filtered through a 45 µm sieve, and the residue on the sieve is quantified. Specifically, the amount of residue observed on the 45 µm sieve is at most 2% by weight, particularly at most 1% by weight, and especially at most 0.5% by weight, based on the total weight of the tested liquid formulation of the invention. In particular, no residue is observed after filtering the aqueous dilution of the formulation of the invention through a 45 µm sieve. The test can be performed using a CIPAC MT 36.3.

[0039] The prefix C used herein and throughout this specification in conjunction with the compound or molecular part n -C m Each indicates the range of possible carbon atoms that a molecular moiety or compound can have. The term "C1-C" n "Alkyl" refers to the group of straight-chain or branched saturated hydrocarbon groups having 1 to n carbon atoms. The term "C"... n / C m "Alkyl" indicates a mixture of two alkyl groups, one with n carbon atoms and the other with m carbon atoms.

[0040] For example, the term C1-C 20 Alkyl groups refer to the group of straight-chain or branched saturated hydrocarbon groups having 1 to 20 carbon atoms, while the terms C1-C4 alkyl refer to the group of straight-chain or branched saturated hydrocarbon groups having 1 to 4 carbon atoms, and C5-C6 alkyl refer to the group of straight-chain or branched saturated hydrocarbon groups having 1 to 4 carbon atoms. 20Alkyl groups represent the group consisting of straight-chain or branched saturated hydrocarbon groups having 5 to 20 carbon atoms. Examples of alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, 2-methylpropyl (isopropyl), 1,1-dimethylethyl (tert-butyl), pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2, 2-Trimethylpropyl, 1-Ethyl-1-methylpropyl, 1-Ethyl-2-methylpropyl, n-Heptyl, 2-Heptyl, n-Octyl, 2-Octyl, 2-Ethylhexyl, Nonyl, Isononyl, Decyl, Undecyl, Dodecyl, Tridecyl, Isotridecyl, Tetradecyl, Pentadecyl, Hexadecyl, Heptadecanyl, Octadecanyl, Nonadecanyl, Eicosyl, Dodecyl, Dodecyl, Isotridecyl, Tetradecyl, Pentadecyl, Hexadecyl, Heptadecanyl, Octadecanyl, Nonadecanyl, Eicosyl, Dodecyl, Dodecyl, Isotridecyl, Tetradecyl, Pentadecyl, Hexadecyl, Octadecanyl, Nonadecanyl, Eicosyl, Dodecyl, Dodecyl, and Dodecyl, and their isomers, especially mixtures of isomers, such as "Isononyl" and "Isodecyl". Examples of C1-C4-alkyl groups are, for example, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, or 1,1-dimethylethyl.

[0041] The liquid formulation of the present invention comprises at least one herbicide belonging to the group consisting of protoporphyrinogen-IX-oxidase inhibitors (PPO inhibitors). A PPO inhibitor is a compound having a mode of action including inhibition of chlorophyll biosynthesis in plants and belonging to group E of the HRAC classification system (see HRAC, classification of herbicides according to mode of action, http: / / www.plantprotection.org / hrac / MOA.html).

[0042] PPO inhibitors typically have the following chemical formula (I):

[0043] (I)

[0044] Some of them

[0045]

[0046] The term represents a heterocycle with N-bonding of formula (a), (b), (c), (d), (e), (f), or (g).

[0047]

[0048] (a) (b) (c) (d) (e)

[0049]

[0050] (f) (g)

[0051] Furthermore, the other variables in equation (I) have the following meanings:

[0052] X is H, F, or Cl, especially F;

[0053] Y is either N or CH;

[0054] Q is Cl;

[0055] R is a group having the following formula (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), or (11):

[0056] (1) (2) (3) (4)

[0058] (5) (6) (7) (8)

[0060] (9) (10) (11)

[0062] In formula (4), Y is CH or N and W is OCH3, OC2H5 or NHSO2CH3;

[0063] Alternatively, Q and R together form one of parts (i) and (ii).

[0064]

[0065] (i)(ii).

[0066] The dashed lines in the groups of formulas (a) to (g), (1) to (11), (i) and (ii) indicate their attachment points to the rest of formula (I).

[0067] Examples of compounds having formula (I) include, for example:

[0068] Azafenidin, butafenacil, carfentrazone, cinidon-ethyl, flumiclorac, flumiclorac-pentyl, flumioxazin, fluthiacet, fluthiacet-methyl, oxadiargyl, oxad iazon, pentoxazone, profluazol, saflufenacil, sulfurtrazone, thidiazimin, tiafenacil, trifludimoxazin, [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridinoxy]ethyl acetate (CAS 353292-31-6; S-3100), 3-[7-fluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-1,5-dimethyl-6-thio-[1,3,5]triazinane-2,4-dione (CAS 451484-50-7), 2-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4,5,6,7-tetrahydro-isoindole-1,3-dione (CAS 1300118-96-0), 1-methyl-6-trifluoromethyl-3-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-1H-pyrimidin-2,4-dione (CAS 1304113-05-0), 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)-1H-pyrimidin-2,4-dione (CAS 1304113-05-0), 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)-1H-pyrimidin-2,4-dione (CAS 1300118-96-0), 1-methyl-6- ...-3-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-1H-pyrimidin-2,4-dione (CAS 1304113-05-0), 1-methyl-6-trifluoromethyl-3-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro 212754-02-4), methyl acetate of 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridyl]oxy]phenoxy]acetate (CAS 2158274-96-3), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-Dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridyl]oxy]phenoxy]ethyl acetate (CAS 2158274-50-9), 2-[[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy]methyl acetate (CAS 2271389-22-9), 2-[[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy]ethyl acetate (CAS 2158274-50 ... 2230679-62-4), methyl acetate 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-acetate (CAS 2158275-73-9), ethyl acetate 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-acetate (CAS 2230679-62-4), methyl acetate 2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-acetate (CAS 2158275-73-9), methyl acetate 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-acetate CAS 2158274-56-5), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]-N-(methanesulfonyl)-acetamide (CAS 2158274-53-2) and 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-N-(methanesulfonyl)-acetamide (CAS 2158276-22-1).

[0069] The first group of particularly preferred PPO inhibitors are those having formula (Ia).

[0070] (Ia)

[0071] Where R is a group having formula (1), (2) or (4), and Y is CH or N.

[0072] Examples of compounds having formula (Ia) include

[0073] Fensulfuron-methyl, flupyrazosulfuron, [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridinoxy]ethyl acetate (CAS 353292-31-6; S-3100), 1-methyl-6-trifluoromethyl-3-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-1H-pyrimidin-2,4-dione (CAS 1304113-05-0), 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)-1H-pyrimidin-2,4-dione (CAS 212754-02-4), methyl acetate of 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]acetate (CAS 2158274-96-3), ethyl acetate of 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]acetate (CAS 2158274-96-3) 2158274-50-9), methyl acetate 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy] (CAS 2158275-73-9), ethyl acetate 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy] (CAS 2158274-50-9) 2158274-56-5), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]-N-(methanesulfonyl)acetamide (CAS 2158274-53-2), and 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-N-(methanesulfonyl)acetamide (CAS 2158274-22-1).

[0074] Particularly preferred are compounds having formula (Ia), selected from the group consisting of: sulfadiazine, flupyrazosulfuron, ethyl acetate [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridinoxy] (CAS 353292-31-6; S-3100), ethyl acetate 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy] (CAS 353292-31-6; S-3100) 2158274-50-9), methyl acetate 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy] (CAS 2158275-73-9), ethyl acetate 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy] (CAS 2158274-50-9) 2158274-56-5), and 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-N-(methanesulfonyl)acetamide (CAS 2158276-22-1).

[0075] The second group of particularly preferred PPO inhibitors are those having formula (Ib).

[0076] (Ib)

[0077] Where X is F or Cl, R is a group having formula (3), (4) or (5), and Y is CH or N.

[0078] Examples of compounds having formula (Ib) include oxadiazine, oxadiazol, mesotrione, methyl acetate, 2-[[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy]ethyl acetate (CAS 2271389-22-9), and ethyl acetate (CAS 2-[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy] 2230679-62-4), particularly preferred are acetamiprid, mesotrione, and ethyl acetate of 2-[[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy] (CAS 2230679-62-4).

[0079] The third group of particularly preferred PPO inhibitors are those having formula (I), wherein

[0080] The group having formula (c) is referred to below as compound (Ic). In compound (Ic), X, Y, Q and R are as defined for formula (I), and X is in particular H or F, Y is in particular CH, Q is in particular Cl and R is in particular group (6), (10) or (11), or R and Q together form group (i) or (ii).

[0081] Examples of compounds having formula (Ic) include indole-3-methyl, flumethrin, amyl flumethrin, propyzoxyl, 2-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4,5,6,7-tetrahydro-isoindole-1,3-dione (CAS 1300118-96-0), with propyzoxyl being particularly preferred.

[0082] The fourth group of particularly preferred PPO inhibitors are those having formula (I), wherein

[0083] The group having formula (d) is referred to below as compound (Id). In compound (Id), X is particularly F, Y is CH or N, and R and Q are as defined herein and particularly together form group (i) or (ii). Examples of compounds having formula (Ic) include trifluralin and 3-[7-fluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-1,5-dimethyl-6-thio-[1,3,5]triazine-2,4-dione (CAS451484-50-7), with trifluralin being particularly preferred.

[0084] The formulations of the present invention are particularly suitable for providing high loading capacity and storage stability in the following cases, wherein the PPO inhibitor is selected from compounds having formulas (Ia) and (Id), and wherein the PPO inhibitor herbicide of component A is particularly selected from the group consisting of pyrimisulfuron and trifluralin.

[0085] Therefore, the particularly preferred set of embodiments (1) relates to the liquid formulation of the present invention, wherein component A is a compound having formula (Ia) and in particular pyrimisulfuron.

[0086] Furthermore, the particularly preferred embodiment group (2) relates to the liquid formulation of the present invention, wherein component A is a compound having formula (Id) and in particular trifluralin.

[0087] In the formulations of the present invention, particularly in the formulations of Examples (1) and (2), the concentration of component A, based on the total weight of the formulation, is often at least 1% by weight, particularly at least 2% by weight, particularly at least 4% by weight, and may be up to 30% by weight. Preferably, in the formulations of the present invention, particularly in the formulations of Examples (1) and (2), the concentration of component A, based on the total weight of the formulation, is in the range of 1% to 30% by weight, particularly in the range of 2% to 25% by weight, particularly 4% to 25% by weight, or 4% to 20% by weight, or 4% to 15% by weight, or 4% to 11% by weight, or 7% to 15% by weight.

[0088] The liquid formulation of the present invention optionally comprises, as component B, at least one acid having a pKA of 1 to 6, preferably 3 to 5, and especially 3.5 to 4.5. The pKA value refers to the value measured in a 0.1 M aqueous solution of the acid in deionized water at 20°C.

[0089] Often, component B is a monocarboxylic acid, dicarboxylic acid, or tricarboxylic acid having, for example, 1 to 6 carbon atoms. Preferably, component B is soluble in water, particularly in an amount of at least 100 g / L. For example, component B may be selected from compounds in the group consisting of:

[0090] -C1-C4-alkanoic acids, such as formic acid, acetic acid, and propionic acid;

[0091] -C2-C4-alkanoic acids, such as oxalic acid, malonic acid, and succinic acid;

[0092] -Hydroxy-C2-C4-alkyl acids, such as glycolic acid and lactic acid; and

[0093] -Hydroxy-C3-C4-alkanoic acid, such as malic acid.

[0094] In particular, component B contains or is selected from C1-C4-alkanoic acids, especially acetic acid.

[0095] The total amount of component B (if present) shall not exceed 5% by weight based on the total weight of the preparation, particularly 4% by weight, especially 3% by weight, more specifically 2% by weight, and even more specifically 1.5% by weight. In particular, based on the total weight of the preparation, the total amount of component B (if present) is typically 0.01% to 5% by weight, particularly 0.03% to 4% by weight, preferably 0.03% to 3% by weight, more preferably 0.03% to 2% by weight, and especially 0.03% to 1.5% by weight.

[0096] In a preferred embodiment, component B is present in the preparation.

[0097] In another preferred embodiment, component B is not present in the preparation.

[0098] The liquid formulation of the present invention comprises a combination of components C1 to C5 as component C. Component C is a combination of specific emulsifiers C3 and C4, and also comprises water and a combination of organic solvents C2 and C5.

[0099] Based on the total weight of the formulation, the total amount of component C is typically at least 65% by weight, particularly at least 70% by weight, and especially at least 71% by weight. Typically, if component B is present, the total amount of component C, based on the total weight of the formulation, is in the range of 65% to 98.99% by weight, particularly in the range of 70% to 97.97% by weight, preferably in the range of 71% to 95.97% by weight, or in the range of 72% to 95.97% by weight, particularly in the range of 75% to 95.97% by weight, or 77% to 95.97% by weight, or 83% to 92.97% by weight. If component B is absent, the total amount of component C, based on the total weight of the preparation, is generally in the range of 65% to 99% by weight, particularly in the range of 70% to 96% by weight, preferably in the range of 75% to 96% by weight, more preferably in the range of 80% to 96% by weight, particularly in the range of 85% to 96% or 85% to 93% by weight.

[0100] Preferably, if component B is present, the formulation comprises, by weight, 1% to 30% of component A, 0.01% to 5% of component B, and 65% to 98.99% of component C, based on the total weight of the formulation. More preferably, if component B is present, the formulation comprises, by weight, 4% to 25% of component A, 0.03% to 4% of component B, and 71% to 95.97% of component C, based on the total weight of the formulation. Even more preferably, if component B is present, the formulation comprises, by weight, 4% to 20% of component A, 0.03% to 3% of component B, and 77% to 95.97% of component C, based on the total weight of the formulation. Specifically, if component B is present, the preparation comprises, by weight, 4% to 15% of component A, 0.03% to 2% of component B, and 83% to 95.97% of component C based on the total weight of the preparation. More specifically, if component B is present, the preparation comprises, by weight, 7% to 15% of component A, 0.03% to 2% of component B, and 83% to 92.97% of component C based on the total weight of the preparation. More specifically, if component B is present, the preparation comprises, by weight, 7% to 11% of component A, 0.03% to 1.5% of component B, and 87.5% to 92.97% of component C based on the total weight of the preparation.

[0101] Preferably, if component B is absent, the preparation comprises 1% to 30% by weight of component A and 70% to 99% by weight of component C based on the total weight of the preparation. More preferably, if component B is absent, the preparation comprises 4% to 25% by weight of component A and 75% to 96% by weight of component C based on the total weight of the preparation. Even more preferably, if component B is absent, the preparation comprises 4% to 20% by weight of component A and 80% to 96% by weight of component C based on the total weight of the preparation. In particular, if component B is absent, the preparation comprises 4% to 15% by weight of component A and 85% to 96% by weight of component C based on the total weight of the preparation. Specifically, if component B is not present, the preparation comprises 4% to 11% of component A by weight based on the total weight of the preparation, and 89% to 96% of component C by weight based on the total weight of the preparation.

[0102] Component C1 is preferably deionized water. Based on the total weight of the formulation, the total amount of component C1 is generally in the range of 0.1% to 10% by weight, preferably in the range of 0.3% to 5% by weight, or 0.1% to 3% by weight, or 0.1% to 2.5% by weight, or 0.3% to 2.5% by weight, more preferably in the range of 0.4% to 3% by weight and 0.4% to 2.5% by weight.

[0103] According to the invention, component C comprises at least one water-miscible solvent as component C2. In the context of this invention, the term "water-miscible solvent" means a solvent that can be mixed in water at a concentration of at least 50 g / L, particularly at least 100 g / L, particularly at least 150 g / L, and preferably at least 200 g / L, at 20°C and 1013 mbar, thereby forming a homogeneous mixture with water. Specifically, component C2 can be completely mixed with water in any ratio. Therefore, the organic solvent of component C2 typically has a solubility of at least 50 g / L, particularly at least 100 g / L, particularly at least 150 g / L, and preferably at least 200 g / L in deionized water at 20°C and 1013 mbar.

[0104] Typically, component C2 is selected from the group consisting of: 1-methoxy-2-propyl acetate, C1-C4-alkyl lactate (such as ethyl lactate or butyl lactate), C1-C4-alkyl lactamide (such as methyl lactamide, ethyl lactamide, propyl lactamide, isopropyl lactamide, or n-butyl lactamide), di-C1-C2-alkyl lactamide (such as N,N-dimethyl lactamide or N,N-diethyl lactamide), N-C1-C4-alkyl-2- Pyrrolidones (such as N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-propyl-2-pyrrolidone, N-isopropyl-2-pyrrolidone or N-(n-butyl)-2-pyrrolidone), ε-caprolactam, C4-C6-lactones (such as γ-butyrolactone or γ-valerolactone), C2-C4-alkylene carbonates (such as ethylene carbonate and propylene carbonate), dimethyl sulfoxide, N,N-dimethylimidazoline-2-one and mixtures thereof.

[0105] Specifically, component C2 is selected from the group consisting of: 1-methoxy-2-propyl acetate, N-C1-C4-alkyl-2-pyrrolidone (such as N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-propyl-2-pyrrolidone, N-isopropyl-2-pyrrolidone or N-(n-butyl)-2-pyrrolidone), ε-caprolactam, C4-C6-lactone (such as γ-butyrolactone or γ-valerolactone), dimethyl sulfoxide, N,N-dimethylimidazoline-2-one and mixtures thereof.

[0106] In a particularly preferred embodiment of the invention, component C2 comprises or is composed of dimethyl sulfoxide (DMSO). Component C2 may also be a mixture comprising DMSO and at least one other organic solvent C2, which is particularly selected from the group consisting of: N-C1-C4-alkyl-2-pyrrolidone (such as N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-propyl-2-pyrrolidone, N-isopropyl-2-pyrrolidone, or N-(n-butyl)-2-pyrrolidone), ε-caprolactam, C4-C6-lactone (such as γ-butyrolactone or γ-valerolactone), and N,N-dimethylimidazolin-2-one. In particular, the amount of DMSO in component C2 is at least 50% by weight based on the total amount of component C2. Specifically, component C2 is dimethyl sulfoxide (DMSO).

[0107] Specifically, based on the total weight of the formulation, the total amount of component C2 is in the range of 10% to 55% by weight, preferably 20% to 50% by weight, more preferably 25% to 50% by weight, and particularly 28% to 45% by weight. The total amount of components C1 and C2 is generally at least 10% by weight based on the total weight of component C, preferably at least 20% by weight, and more preferably at least 30% by weight. Specifically, the total amount of components C1 and C2 is in the range of 10% to 85% by weight based on the total weight of component C, preferably 20% to 60% by weight, and more preferably 20% to 50% by weight.

[0108] Specifically, the relative amount of component C1 is based on the total weight of components C1 and C2 being in the range of 0.5% to 20% by weight, preferably in the range of 1% to 10% by weight, and particularly in the range of 1% to 5% by weight; and the relative amount of component C2 is based on the total weight of components C1 and C2 being in the range of 80% to 99.5% by weight, preferably in the range of 90% to 99% by weight, and particularly in the range of 95% to 99% by weight. Preferably, the relative amount of components C1 and C2 can vary from 1:100 to 20:1, particularly from 1:70 to 10:1, more particularly from 1:70 to 11:1, and even more particularly from 1:10 to 1:65.

[0109] Component C contains at least one first emulsifier as component C3, selected from the group consisting of: C6-C 25 -Alkyl alcohol alkoxylates, C6-C 25 - Alkenol alkoxylates and mixtures thereof.

[0110] Alkyl alcohol alkoxylates and enol alkoxylates typically pass through epoxides (especially C2-C4-epoxides) with C6-C... 25 - Alkyl alcohol or C6-C 25 It is obtained by the addition reaction of α-alkenol. Therefore, alkoxylates are polyethers having repeating oxidized olefin units derived from one or more epoxides used in the preparation of the respective alkoxylates.

[0111] Examples of C2-C4-epoxides are ethylene oxide (EO), propylene oxide (PO), and butane oxide, with ethylene oxide, propylene oxide, and combinations thereof being preferred.

[0112] C6-C 25 - Alkanols and C6-C 25 - Alkenols can be straight-chain or branched. C6-C 25- Alkenols can have 1, 2, 3, or 4, especially 1 or 2, olefinic unsaturated double bonds, and can have cis or trans configurations. If the alkenol is derived from vegetable oil, the C-C double bond usually has a cis configuration.

[0113] Straight chain C6-C 25 Examples of alkanols include, but are not limited to, hexanol, heptanol, octanol, nonanol, decanol, undecanol, dodecanol (laurate alcohol), tridecanol, tetradecanol (myristol), pentadecanol, hexadecanol (cetyl alcohol), heptadecanol, octadecanol (stearyl alcohol), nonadecanol, eicosanool, docosanool, tridecanol, tetradecanol (wood wax alcohol), and pentadecanol. Branched C6-C 25 Examples of alkanols include, but are not limited to, branched alkanols such as 2-methylpentanol, 2,2-dimethylbutanol, 2-ethylbutanol, 2-ethylhexanol, 1-methylheptadecanool, 1-hexylheptanol, isodecanol, and isotrigineol. Examples of straight-chain enols include, but are not limited to, hexenol, heptenol, octenol, nonenol, decenol, undecenol, dodecadecenol, tridecenol, tetradecenol, pentadecenol, hexadecenol, pentadecenol, hexadecenol, heptadecadecenol, octadecenol (oleyl alcohol), nonadecadecenol, eicosenodecenol, dodecenol, dodecenol, dodecenol, dodecenol, dodecenol, dodecenol, dodecenol, and dodecenol. Examples of branched alkanols include, but are not limited to, isohexenol, 2-ethylhexenol, dimethyloctenol, isotrigineol, 1-methylheptadecenol, 1-hexylheptenol, isotrigineol, isophyllol, and isoctadecenol.

[0114] Throughout this specification, the terms "alkoxylation" and "polyalkoxylation" are used synonymously and refer to compounds having oligomeric or polyoxyalkylene groups formed by repeating units OA (where A is alkylene, particularly C2-C4-alkylene). In this context, the term "degree of alkoxylation" refers to the average number of repeating units OA in these compounds.

[0115] Preferably, the degree of alkoxylation does not exceed 10. In particular, the degree of alkoxylation of alkanol alkoxylates is in the range of 1 to 10, preferably in the range of 2 to 7, and especially in the range of 3 to 5. Similarly, in particular, the degree of alkoxylation of enol alkoxylates is in the range of 1 to 10, preferably in the range of 2 to 7, and especially in the range of 3 to 5.

[0116] C8-C is preferred. 20 -Alkanols-C2-C4-alkoxylates and C8-C 20 -Alkenol-C2-C4-alkoxylates, with C2-C4-alkoxylates being particularly preferred. 10 -C 18-Alkyl alcohols-C2-C4-alkoxylates and C 10 -C 18 -Alkenol-C2-C4-alkoxylates.

[0117] C6-C is preferred. 25 -Alkanol ethoxylates, C6-C 25 -Alkenol ethoxylates, C6-C 25 -Alkanol propoxylates, C6-C 25 - Alkenol propoxylate, C6-C 25 -Alkanol ethoxylates-co-propoxylates and C6-C 25 -Alkenol ethoxylate-co-propoxylate, with C8-C being particularly preferred. 20 -Alkanol ethoxylates, C8-C 20 -Alkenol ethoxylates, C8-C 20 -Alkanol ethoxylates-co-propoxylates and C8-C 20 -Alkenol ethoxylate-co-propoxylate, more particularly preferred is C 10 -C 18 -Alkanol ethoxylates, C 10 -C 18 -Alkenol ethoxylate, C 10 -C 18 -Alkanol ethoxylates-co-propoxylates and C 10 -C 18 -Alkenol ethoxylate-co-propoxylate, with C being particularly preferred. 10 -C 18 - Alkyl alcohol ethoxylates and C 10 -C 18 - Alkenol ethoxylates.

[0118] C6-C is particularly preferred. 25 - Alkyl alcohol ethoxylates and C6-C 25 -Alkenol ethoxylates, more particularly preferred are C8-C 20 -Alkanol ethoxylates and C8-C 20 -Alkenol ethoxylates, especially C14 are preferred. 10 -C 18 - Alkyl alcohol ethoxylates and C 10 -C 18 - Alkenol ethoxylates, wherein the degree of ethoxylation of the alkenol ethoxylates is in the range of 1 to 10, particularly in the range of 2 to 7, and especially in the range of 3 to 5.

[0119] Based on the total weight of the preparation, the amount of component C3 is typically in the range of 3% to 35% by weight, preferably 4% to 30% by weight, and more preferably 5% to 30% by weight.

[0120] According to the present invention, component C comprises at least one second emulsifier as component C4, selected from the group consisting of: polyarylphenol ethoxylates, particularly stilbene phenol ethoxylates, tristilbene phenol ethoxylates, and mixtures thereof.

[0121] Both stilbene phenol ethoxylate and tristilbene phenol ethoxylate are ethoxylated polyarylphenols. These ethoxylated polyarylphenols have two phenyl vinyl groups (=styryl) and three phenyl vinyl groups, respectively, which are attached to the benzene ring of the phenol unit that makes up the molecule.

[0122] Preferably, the degree of ethoxylation of component C4 is in the range of 1 to 30, particularly in the range of 5 to 20, and particularly in the range of 10 to 18.

[0123] Preferably, component C4 is selected from the group consisting of stilbene phenol ethoxylates, tristilbene phenol ethoxylates, and mixtures thereof, each having an ethoxylation degree in the range of 1 to 30, particularly in the range of 5 to 20, particularly in the range of 10 to 18.

[0124] Specifically, component C4 is selected from the group consisting of tristyrylphenol ethoxylates having an ethoxylation degree in the range of 2 to 30, particularly in the range of 5 to 20, particularly in the range of 10 to 18, and mixtures thereof.

[0125] Examples of ethoxylated polyarylphenols are commercially available from Solvay as Soprophor® 796 / p. Examples of ethoxylated tristyrylphenols are commercially available from Solvay as Soprophor® S / 25 or Soprophor® BSU.

[0126] Typically, based on the total weight of the preparation, the amount of component C4 is in the range of 3% to 30% by weight, particularly in the range of 4% to 25% by weight, particularly in the range of 4% to 20% by weight.

[0127] Based on the total weight of component C, the total amount of components C3 and C4 is generally in the range of 5% to 85% by weight, preferably 10% to 50% by weight, and more preferably 10% to 40% by weight.

[0128] Specifically, the relative amount of component C3 is based on the total weight of components C3 and C4, ranging from 30% to 90% by weight, preferably from 35% to 90% by weight, and particularly from 40% to 90% by weight; and the relative amount of component C4 is based on the total weight of components C3 and C4, ranging from 10% to 70% by weight, preferably from 10% to 65% by weight, and particularly from 10% to 60% by weight. Preferably, the relative amounts of components C3 and C4 can vary from 1:5 to 10:1, particularly from 1:2 to 10:1, and even more particularly from 1:1.5 to 7:1.

[0129] The liquid formulation of the present invention further contains at least one C6-C as component C5. 20 -Fatty acids-C1-C4-alkyl esters, especially C6-C 20 - Fatty acid methyl esters or C6-C 20 -Ethyl fatty acid esters.

[0130] In a particular embodiment, component C5 comprises at least one C 18 -Fatty acids -C1-C4-alkyl esters, especially C 18 - Fatty acid methyl esters or C 18 -Ethyl fatty acid esters.

[0131] In this particular embodiment, based on the total weight of component C5, component C5 comprises at least 60% by weight, preferably at least 70% by weight, and particularly at least 80% by weight of at least one C 18 - Fatty acid - C1-C4-alkyl ester.

[0132] It has been found that it is beneficial if component C5 contains the following items.

[0133] -Based on the total weight of component C5, at least one C (by weight) not exceeding 21%. 10 -C 17 -Fatty acid-C1-C4-alkyl esters,

[0134] -Based on the total weight of component C5, at least one C (by weight) not exceeding 2%. 19 -C 20 -Fatty acid-C1-C4-alkyl esters,

[0135] -Based on the total weight of this component (C5) not exceeding 8% by weight of C1-C4 alkyl palmitic acid esters, and

[0136] - The total weight of stearic acid C1-C4-alkyl esters based on component C5) does not exceed 4% by weight.

[0137] Specifically, component C5 contains

[0138] -Based on the total weight of component C5, at least one C (by weight) not exceeding 21%. 10 -C 17 -Fatty acid-C1-C4-alkyl esters,

[0139] -Based on the total weight of component C5, at least one C (by weight) not exceeding 2%. 19 -C 20 -Fatty acid-C1-C4-alkyl esters,

[0140] -Based on the total weight of component C5, not exceeding 8% by weight of methyl palmitate, and

[0141] - Methyl stearate, based on the total weight of component C5, not exceeding 4% by weight.

[0142] C6-C 20 Examples of C1-C4-alkyl esters of fatty acids include, but are not limited to, methyl esters, ethyl esters, propyl esters and butyl esters, with methyl esters and ethyl esters being particularly preferred.

[0143] Here, C6-C 20 - Fatty acid-C1-C4-alkyl esters C6-C 20 - Fatty acids can be saturated or unsaturated. Here, C6-C... 20 - Fatty acid-C1-C4-alkyl esters C6-C 20 - Fatty acids can be single fatty acids or mixtures of fatty acids. Alkyl esters of fatty acids are prepared by any well-known method, such as transesterification of vegetable fats and oils.

[0144] C6-C 20 Examples of fatty acids include, but are not limited to, hexanoic acid, enanthic acid, octanoic acid, nonanoic acid, decanoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, arachidonic acid, and eicosapentaenoic acid and mixtures thereof. 18 Examples of - fatty acid -C1-C4-alkyl esters include, but are not limited to, methyl, ethyl, propyl, and butyl esters of stearic acid, oleic acid, linoleic acid, and linolenic acid.

[0145] In a preferred embodiment of the invention, component C5 is a methylated vegetable oil or a mixture of methylated vegetable oils, particularly selected from the group consisting of: methylated rapeseed oil, methylated sunflower oil, methylated soybean oil, methylated peanut oil, methylated olive oil, methylated corn oil, methylated grapeseed oil, methylated safflower oil, methylated sesame oil, methylated manure palm fruit oil, methylated low-erucic acid rapeseed oil, and methylated hemp seed oil.

[0146] In a particular embodiment, component C5 contains at least one C 18 -Fatty acids -C1-C4-alkyl esters, especially C 18 - Fatty acid methyl esters or C 18 In the case of -fatty acid ethyl esters, at least one C 18 The weight ratio of fatty acid-C1-C4-alkyl esters to other components constituting component C5 is preferably in the range of 4:1 to 3:2, particularly in the range of 3:1 to 2.5:1.

[0147] In this particular embodiment, at least one C 10 -C 17 -Fatty acid-C1-C4-alkyl esters and at least one C 19 -C 20 The weight ratio of -fatty acid -C1-C4-alkyl esters to methyl palmitate to methyl stearate is in the range of 5.25 : 0.5 : 2 : 1 to 1 : 2.5 : 0.4 : 0.2, particularly in the range of 4 : 0.6 : 1.5 : 1 to 2 : 2 : 0.5 : 0.5.

[0148] In another specific embodiment, component C5 comprises or consists of the following items: C6-C 10 - Fatty acid C1-C4-alkyl esters, preferably methyl esters; preferably saturated C6-C4 alkyl esters. 10 - Fatty acid C1-C4-alkyl esters, preferably methyl esters; more preferably saturated C8-C4 alkyl esters. 10 - Fatty acid C1-C4-alkyl esters, preferably methyl esters.

[0149] Based on the total weight of component C, the total amount of component C5 is typically in the range of 5% to 80% by weight, preferably 10% to 60% by weight, and more preferably 20% to 40% by weight.

[0150] Specifically, component C contains

[0151] -Based on the total weight of component C), components C1) and C2) comprise 10% to 85%, preferably 20% to 60%, and more preferably 20% to 50% by weight.

[0152] -Based on the total weight of component C), components C3) and C4) comprise 5% to 85%, preferably 10% to 50%, and more preferably 10% to 40% by weight.

[0153] - 5% to 80% by weight, preferably 10% to 60% by weight, and more preferably 20% to 40% by weight of component C5, based on the total weight of component C).

[0154] More specifically, component C contains

[0155] - Component C1, based on the total weight of component C, is 0.1% to 10% by weight, preferably 0.3% to 5% by weight, and more preferably 0.4% to 3% by weight.

[0156] -Component C2 comprising 10% to 55% by weight of component C, preferably 20% to 50% by weight, and more preferably 20% to 45% by weight of component C.

[0157] - Component C3 comprising 3% to 35% by weight, preferably 4% to 30% by weight, and more preferably 5% to 30% by weight of component C.

[0158] - Component C4 comprising 3% to 30% by weight, preferably 4% to 25% by weight, and more preferably 4% to 20% by weight of component C.

[0159] - Component C5, based on the total weight of component C, is 5% to 80% by weight, preferably 10% to 60% by weight, and more preferably 20% to 40% by weight.

[0160] In particular, the liquid formulation according to the invention comprises

[0161] a) at least one of pyrimethanil and trifluralin as component A),

[0162] b) Optionally, at least one C1-C4-alkanoic acid, particularly acetic acid, as component B), and

[0163] c) The solvent-emulsifier combination as component C), which contains

[0164] c1) Water as component C1),

[0165] c2) is at least one water-miscible solvent for component C2), selected from the group consisting of: 1-methoxy-2-propyl acetate, C1-C4-alkyl lactates (such as ethyl lactate or butyl lactate), C1-C4-alkyl lactamides (such as methyl lactamide, ethyl lactamide, propyl lactamide, isopropyl lactamide or n-butyl lactamide), di-C1-C2-alkyl lactamides (such as N,N-dimethyl lactamide or N,N-diethyl lactamide), N-C1-C4-alkyl- 2-Pyrrolidone (such as N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-propyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone), ε-caprolactam, C4-C6-lactones (such as γ-butyrolactone or γ-valerolactone), C2-C4-alkylene carbonates (such as ethylene carbonate and propylene carbonate), dimethyl sulfoxide, N,N-dimethylimidazoline-2-one and mixtures thereof;

[0166] c3) is at least one first emulsifier of component C3), selected from the group consisting of: C6-C 25 -Alkyl alcohol alkoxylates, C6-C 25 - Alkenol alkoxylates, mixtures thereof, particularly those selected from the group consisting of: C8-C 20 -Alkanols-C2-C4-alkoxylates and C8-C 20 -Alkenol-C2-C4-alkoxylates and mixtures thereof, especially C 10 -C 18 -Alkyl alcohols-C2-C4-alkoxylates and C 10 -C 18 -Alkenol-C2-C4-alkoxylates,

[0167] c4) as at least one second emulsifier of component C4), selected from the group consisting of: stilbene phenol ethoxylate, tristilbene phenol ethoxylate, and mixtures thereof, wherein the degree of ethoxylation of component C4 is in the range of 1 to 30, particularly in the range of 5 to 20, particularly in the range of 10 to 18; and

[0168] c5) as at least one of component C5) 10 -C 20 - Fatty acid-C1-C4-alkyl esters, which contain at least one C 18 - Fatty acid-C1-C4-alkyl esters, wherein the C5 component) is selected from the group consisting of: methylated rapeseed oil, methylated sunflower oil, methylated soybean oil, methylated peanut oil, methylated olive oil, methylated corn oil, methylated grapeseed oil, methylated safflower oil, methylated sesame oil, methylated mangrove fruit oil, methylated low erucic acid rapeseed oil, and methylated hemp seed oil;

[0169] or

[0170] As component C5), at least one saturated C6-C 10 - Fatty acid methyl esters.

[0171] In particular, the liquid formulation according to the invention comprises

[0172] a) at least one of pyrimethanil and trifluralin as component A),

[0173] b) Optionally, at least one C1-C4-alkanoic acid, particularly acetic acid, as component B), and

[0174] c) The solvent-emulsifier combination as component C), which contains

[0175] c1) Water as component C1),

[0176] c2) as at least one water-miscible solvent of component C2), selected from the group consisting of: 1-methoxy-2-propyl acetate, N-C1-C4-alkyl-2-pyrrolidone (such as N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-propyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone), ε-caprolactam, C4-C6-lactone (such as γ-butyrolactone or γ-valerolactone), dimethyl sulfoxide, N,N-dimethylimidazoline-2-one and mixtures thereof;

[0177] c3) is at least one first emulsifier of component C3), selected from the group consisting of: C6-C 25 - Alkyl alcohol ethoxylates and C6-C 25 - Alkenol ethoxylates, more specifically selected from C8-C 20 -Alkanol ethoxylates and C8-C 20 - Alkenol ethoxylates, especially those selected from C 10 -C 18 - Alkyl alcohol ethoxylates and C 10 -C 18 -Alkenol ethoxylates,

[0178] c4) as at least one second emulsifier of component C4), selected from the group consisting of: stilbene phenol ethoxylate, tristilbene phenol ethoxylate, and mixtures thereof, wherein the degree of ethoxylation of component C4 is in the range of 1 to 30, particularly in the range of 5 to 20, particularly in the range of 10 to 18; and

[0179] c5) as at least one of component C5) 10-C 20 - Fatty acid-C1-C4-alkyl esters, which contain at least one C 18 -Fatty acid-C1-C4-alkyl esters, selected from the group consisting of: methylated rapeseed oil, methylated sunflower oil, methylated soybean oil, methylated peanut oil, methylated olive oil, methylated corn oil, methylated grapeseed oil, methylated safflower oil, methylated sesame oil, methylated mangrove fruit oil, methylated low-erucic acid rapeseed oil, and methylated hemp seed oil, wherein the C5 component specifically contains

[0180] -Based on the total weight of component C5, at least one C (by weight) not exceeding 21%. 10 -C 17 -Fatty acid-C1-C4-alkyl esters,

[0181] -Based on the total weight of component C5, at least one C (by weight) not exceeding 2%. 19 -C 20 -Fatty acid-C1-C4-alkyl esters,

[0182] -Based on the total weight of component C5, not exceeding 8% by weight of methyl palmitate, and

[0183] - Methyl stearate, based on the total weight of component C5, not exceeding 4% by weight;

[0184] or

[0185] As component C5), at least one saturated C6-C 10 - Fatty acid methyl esters, which preferably comprise saturated C8-fatty acid methyl esters.

[0186] In particular, the formulation of the present invention comprises

[0187] -Based on the total weight of the preparation, component A comprises 1% to 30% by weight, particularly 2% to 25% by weight, especially 4% to 25% by weight, or 4% to 20% by weight, or 4% to 15% by weight, or 4% to 11% by weight, or 7% to 15% by weight.

[0188] -Based on the total weight of the preparation, component B is 0% to 5% by weight, preferably 0% to 4% by weight, especially 0% to 3% by weight, or 0% to 2% by weight, or 0% to 1.5% by weight, and

[0189] - Component C, based on the total weight of the preparation, is 65% to 99% by weight, particularly 71% to 98% by weight, preferably 72% to 96% by weight, especially 78% to 96% by weight, or 83% to 96% by weight, or 87.5% to 96% by weight, or 83% to 93% by weight.

[0190] Preferably, the formulation of the present invention comprises

[0191] a) Component A, based on the total weight of the preparation, comprises 1% to 30% by weight, particularly 2% to 25% by weight, particularly 4% to 25% by weight, or 4% to 20% by weight, or 4% to 15% by weight, or 4% to 11% by weight, or 7% to 15% by weight.

[0192] b) Component B, based on the total weight of the preparation, at 0% to 5% by weight, preferably 0% to 4% by weight, particularly 0% to 3% by weight, or 0% to 2% by weight, or 0% to 1.5% by weight, and

[0193] c) A solvent-emulsifier combination comprising, by weight 65% to 99%, particularly 71% to 98%, or 72% to 96%, particularly 78% to 96%, or 83% to 96%, or 87.5% to 96%, or 83% to 93% of the total weight of the formulation, as component C), which contains

[0194] -Based on the total weight of component C), 10% to 85%, particularly 20% to 60%, especially 20% to 50% by weight, of water as component C1) and at least one water-miscible solvent as component C2).

[0195] - At least one first emulsifier of component C3) comprising 3% to 35% by weight, particularly 4% to 30% by weight, especially 5% to 30% by weight, based on the total weight of component C), selected from the group consisting of: C6-C 25 -Alkyl alcohol alkoxylates, C6-C 25 - Alkenol alkoxylates, and mixtures thereof

[0196] - At least one second emulsifier of component C4) comprising 3% to 30% by weight, particularly 4% to 25% by weight, and especially 4% to 20% by weight, based on the total weight of component C), selected from the group consisting of: stilbene phenol ethoxylate, tristilbene phenol ethoxylate, and mixtures thereof, and

[0197] - At least one component C5) comprising 5% to 80% by weight, particularly 10% to 60% by weight, and especially 20% to 40% by weight, of the total weight of component C5. 10 -C 20 - Fatty acid-C1-C4-alkyl esters, which contain at least one C 18- Fatty acid - C1-C4-alkyl ester.

[0198] Preferably, the formulation of the present invention may further contain

[0199] a) Component A, based on the total weight of the preparation, comprises 1% to 30% by weight, particularly 2% to 25% by weight, particularly 4% to 25% by weight, or 4% to 20% by weight, or 4% to 15% by weight, or 4% to 11% by weight, or 7% to 15% by weight.

[0200] b) Component B, based on the total weight of the preparation, at 0% to 5% by weight, preferably 0% to 4% by weight, particularly 0% to 3% by weight, or 0% to 2% by weight, or 0% to 1.5% by weight, and

[0201] c) A solvent-emulsifier combination comprising, by weight 65% to 99%, particularly 71% to 98%, or 72% to 96%, particularly 78% to 96%, or 83% to 96%, or 87.5% to 96%, or 83% to 93% of the total weight of the formulation, as component C), which contains

[0202] -Based on the total weight of component C), 10% to 85%, particularly 20% to 60%, especially 20% to 50% by weight, of water as component C1) and at least one water-miscible solvent as component C2).

[0203] - At least one first emulsifier of component C3) comprising 3% to 35% by weight, particularly 4% to 30% by weight, especially 5% to 30% by weight, based on the total weight of component C), selected from the group consisting of: C6-C 25 -Alkyl alcohol alkoxylates, C6-C 25 - Alkenol alkoxylates, and mixtures thereof

[0204] - At least one second emulsifier of component C4) comprising 3% to 30% by weight, particularly 4% to 25% by weight, and especially 4% to 20% by weight, based on the total weight of component C), selected from the group consisting of: stilbene phenol ethoxylate, tristilbene phenol ethoxylate, and mixtures thereof, and

[0205] - At least one saturated C6-C based on the total weight of component C) of 5% to 80%, particularly 10% to 60%, especially 20% to 40% by weight. 10 -Fatty acid-C1-C4-alkyl esters, especially at least one saturated C6-C4 alkyl ester 10- Fatty acid methyl esters or ethyl esters.

[0206] More preferably, the formulation of the present invention comprises

[0207] a) Component A, selected from pyrimethanil and trifluralin and combinations thereof, comprising 1% to 30% by weight, particularly 2% to 25% by weight, particularly 4% to 25% by weight, or 4% to 20% by weight, or 4% to 15% by weight, or 4% to 11% by weight, or 7% to 15% by weight, based on the total weight of the formulation.

[0208] b) Component B, comprising 0% to 5% by weight, preferably 0% to 4% by weight, particularly 0% to 3% by weight, or 0% to 2% by weight, or 0% to 1.5% by weight, based on the total weight of the formulation, which is at least one C1-C4-alkanoic acid, particularly acetic acid, and

[0209] c) A solvent-emulsifier combination comprising, by weight 65% to 99%, particularly 71% to 98%, or 72% to 96%, particularly 78% to 96%, or 83% to 96%, or 87.5% to 96%, or 83% to 93% of the total weight of the formulation, as component C), which contains

[0210] -Based on the total weight of component C), 10% to 85% by weight, particularly 20% to 60% by weight, especially 20% to 50% by weight, of water as component C1) and at least one water-miscible solvent as component C2), wherein the at least one water-miscible solvent is selected from the group consisting of: 1-methoxy-2-propyl acetate, C1-C4-alkyl lactate (such as ethyl lactate or butyl lactate), C1-C4-alkyl lactamide (such as methyl lactamide, ethyl lactamide, propyl lactamide, isopropyl lactamide or n-butyl lactamide), di-C1-C2-alkyl lactamide (such as N,N-dimethyl lactamide or N,N-diethyl lactamide), N-C1- C4-alkyl-2-pyrrolidones (such as N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-propyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone), ε-caprolactam, C4-C6-lactones (such as γ-butyrolactone or γ-valerolactone), C2-C4-alkylene carbonates (such as ethylene carbonate and propylene carbonate), dimethyl sulfoxide, N,N-dimethylimidazoline-2-ones and mixtures thereof.

[0211] - At least one first emulsifier of component C3) comprising 3% to 35% by weight, particularly 4% to 30% by weight, especially 5% to 30% by weight, based on the total weight of component C), selected from the group consisting of: C8-C 20 -Alkanols-C2-C4-alkoxylates and C8-C 20 -Alkenol-C2-C4-alkoxylates and mixtures thereof, especially C 10 -C 18 -Alkyl alcohols-C2-C4-alkoxylates and C 13 -C 10 -Alkyl alcohol-C2-C4-alkoxylates,

[0212] - At least one second emulsifier of component C4, comprising 3% to 30% by weight, particularly 4% to 25% by weight, and especially 4% to 20% by weight, based on the total weight of component C4, selected from the group consisting of: stilbene phenol ethoxylate, tristilbene phenol ethoxylate, and mixtures thereof, wherein the degree of ethoxylation of component C4 is in the range of 1 to 30, particularly in the range of 5 to 20, and especially in the range of 10 to 18, and

[0213] - At least one component C5) comprising 5% to 80% by weight, particularly 10% to 60% by weight, and especially 20% to 40% by weight, of the total weight of component C5. 10 -C 20 - Fatty acid-C1-C4-alkyl esters, which include at least one C 18 - Fatty acid-C1-C4-alkyl esters, wherein the C5 component) is selected from the group consisting of: methylated rapeseed oil, methylated sunflower oil, methylated soybean oil, methylated peanut oil, methylated olive oil, methylated corn oil, methylated grapeseed oil, methylated safflower oil, methylated sesame oil, methylated manure palm fruit oil, methylated low erucic acid rapeseed oil, and methylated hemp seed oil.

[0214] More preferably, the formulation of the present invention may further contain

[0215] a) Component A, selected from pyrimethanil and trifluralin and combinations thereof, comprising 1% to 30% by weight, particularly 2% to 25% by weight, particularly 4% to 25% by weight, or 4% to 20% by weight, or 4% to 15% by weight, or 4% to 11% by weight, or 7% to 15% by weight, based on the total weight of the formulation.

[0216] b) Component B, comprising 0% to 5% by weight, preferably 0% to 4% by weight, particularly 0% to 3% by weight, or 0% to 2% by weight, or 0% to 1.5% by weight, based on the total weight of the formulation, which is at least one C1-C4-alkanoic acid, particularly acetic acid, and

[0217] c) A solvent-emulsifier combination comprising, by weight 65% to 99%, particularly 71% to 98%, or 72% to 96%, particularly 78% to 96%, or 83% to 96%, or 87.5% to 96%, or 83% to 93% of the total weight of the formulation, as component C), which contains

[0218] -Based on the total weight of component C), 10% to 85% by weight, particularly 20% to 60% by weight, especially 20% to 50% by weight, of water as component C1) and at least one water-miscible solvent as component C2), wherein the at least one water-miscible solvent is selected from the group consisting of: 1-methoxy-2-propyl acetate, C1-C4-alkyl lactate (such as ethyl lactate or butyl lactate), C1-C4-alkyl lactamide (such as methyl lactamide, ethyl lactamide, propyl lactamide, isopropyl lactamide or n-butyl lactamide), di-C1-C2-alkyl lactamide (such as N,N-dimethyl lactamide or N,N-diethyl lactamide), N-C1- C4-alkyl-2-pyrrolidones (such as N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-propyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone), ε-caprolactam, C4-C6-lactones (such as γ-butyrolactone or γ-valerolactone), C2-C4-alkylene carbonates (such as ethylene carbonate and propylene carbonate), dimethyl sulfoxide, N,N-dimethylimidazoline-2-ones and mixtures thereof.

[0219] - At least one first emulsifier of component C3) comprising 3% to 35% by weight, particularly 4% to 30% by weight, especially 5% to 30% by weight, based on the total weight of component C), selected from the group consisting of: C8-C 20 -Alkanols-C2-C4-alkoxylates and C8-C 20 -Alkenol-C2-C4-alkoxylates and mixtures thereof, especially C 10 -C 18 -Alkyl alcohols-C2-C4-alkoxylates and C 13 -C 10 -Alkyl alcohol-C2-C4-alkoxylates,

[0220] - At least one second emulsifier of component C4, comprising 3% to 30% by weight, particularly 4% to 25% by weight, and especially 4% to 20% by weight, based on the total weight of component C4, selected from the group consisting of: stilbene phenol ethoxylate, tristilbene phenol ethoxylate, and mixtures thereof, wherein the degree of ethoxylation of component C4 is in the range of 1 to 30, particularly in the range of 5 to 20, and especially in the range of 10 to 18, and

[0221] - At least one C6-C of component C5) comprising 5% to 80% by weight, particularly 10% to 60% by weight, and especially 20% to 40% by weight, of the total weight of component C). 10 -Fatty acid-C1-C4-alkyl esters, especially at least one C6-C 10 - Fatty acid methyl esters or ethyl esters, which contain at least one C8-fatty acid-C1-C4-alkyl ester, particularly at least one C8-fatty acid methyl ester or ethyl ester.

[0222] In particular, the formulation of the present invention comprises

[0223] a) Component A, selected from pyrimethanil and trifluralin and combinations thereof, comprising 1% to 30% by weight, particularly 2% to 25% by weight, particularly 4% to 25% by weight, or 4% to 20% by weight, or 4% to 15% by weight, or 4% to 11% by weight, or 7% to 15% by weight, based on the total weight of the formulation.

[0224] b) Component B, comprising 0% to 5% by weight, preferably 0% to 4% by weight, particularly 0% to 3% by weight, or 0% to 2% by weight, or 0% to 1.5% by weight, based on the total weight of the formulation, which is at least one C1-C4-alkanoic acid, particularly acetic acid, and

[0225] c) A solvent-emulsifier combination comprising, by weight 65% to 99%, particularly 71% to 98%, or 72% to 96%, particularly 78% to 96%, or 83% to 96%, or 87.5% to 96%, or 83% to 93% of the total weight of the formulation, as component C), which contains

[0226] -Based on the total weight of component C), 10% to 85% by weight, particularly 20% to 60% by weight, especially 20% to 50% by weight, of water as component C1) and at least one water-miscible solvent as component C2), selected from the group consisting of: 1-methoxy-2-propyl acetate, N-C1-C4-alkyl-2-pyrrolidone (such as N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-propyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone), ε-caprolactam, C4-C6-lactone (such as γ-butyrolactone or γ-valerolactone), dimethyl sulfoxide, N,N-dimethylimidazoline-2-one and mixtures thereof;

[0227] - At least one first emulsifier of component C3) comprising 3% to 35% by weight, particularly 4% to 30% by weight, especially 5% to 30% by weight, based on the total weight of component C), selected from the group consisting of: C6-C 25 - Alkyl alcohol ethoxylates and C6-C 25 - Alkenol ethoxylates, more specifically selected from C8-C 20 -Alkanol ethoxylates and C8-C 20 - Alkenol ethoxylates, especially those selected from C 10 -C 18 - Alkyl alcohol ethoxylates and C 10 -C 18 -Alkenol ethoxylates,

[0228] - At least one second emulsifier of component C4, comprising 3% to 30% by weight, particularly 4% to 25% by weight, and especially 4% to 20% by weight, based on the total weight of component C4, selected from the group consisting of: stilbene phenol ethoxylate, tristilbene phenol ethoxylate, and mixtures thereof, wherein the degree of ethoxylation of component C4 is in the range of 1 to 30, particularly in the range of 5 to 20, and especially in the range of 10 to 18, and

[0229] - At least one C6-C of component C5) comprising 5% to 80% by weight, particularly 10% to 60% by weight, and especially 20% to 40% by weight, of the total weight of component C). 20 - Fatty acid-C1-C4-alkyl esters, which contain at least one C 18-Fatty acid-C1-C4-alkyl esters, wherein the C5 component) is selected from the group consisting of: methylated rapeseed oil, methylated sunflower oil, methylated soybean oil, methylated peanut oil, methylated olive oil, methylated corn oil, methylated grapeseed oil, methylated safflower oil, methylated sesame oil, methylated manure palm fruit oil, methylated low erucic acid rapeseed oil, and methylated hemp seed oil.

[0230] Component C5 specifically contains

[0231] -Based on the total weight of component C5, at least one C (by weight) not exceeding 21%. 10 -C 17 -Fatty acid-C1-C4-alkyl esters,

[0232] -Based on the total weight of component C5, at least one C (by weight) not exceeding 2%. 19 -C 20 -Fatty acid-C1-C4-alkyl esters,

[0233] -Based on the total weight of component C5, not exceeding 8% by weight of methyl palmitate, and

[0234] - Methyl stearate, based on the total weight of component C5, not exceeding 4% by weight.

[0235] In particular, the formulation of the present invention may also contain

[0236] a) Component A, selected from pyrimethanil and trifluralin and combinations thereof, comprising 1% to 30% by weight, particularly 2% to 25% by weight, particularly 4% to 25% by weight, or 4% to 20% by weight, or 4% to 15% by weight, or 4% to 11% by weight, or 7% to 15% by weight, based on the total weight of the formulation.

[0237] b) Component B, comprising 0% to 5% by weight, preferably 0% to 4% by weight, particularly 0% to 3% by weight, or 0% to 2% by weight, or 0% to 1.5% by weight, based on the total weight of the formulation, which is at least one C1-C4-alkanoic acid, particularly acetic acid, and

[0238] c) A solvent-emulsifier combination comprising, by weight 65% to 99%, particularly 71% to 98%, or 72% to 96%, particularly 78% to 96%, or 83% to 96%, or 87.5% to 96%, or 83% to 93% of the total weight of the formulation, as component C), which contains

[0239] -Based on the total weight of component C), 10% to 85% by weight, particularly 20% to 60% by weight, especially 20% to 50% by weight, of water as component C1) and at least one water-miscible solvent as component C2), selected from the group consisting of: 1-methoxy-2-propyl acetate, N-C1-C4-alkyl-2-pyrrolidone (such as N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-propyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone), ε-caprolactam, C4-C6-lactone (such as γ-butyrolactone or γ-valerolactone), dimethyl sulfoxide, N,N-dimethylimidazoline-2-one and mixtures thereof;

[0240] - At least one first emulsifier of component C3) comprising 3% to 35% by weight, particularly 4% to 30% by weight, especially 5% to 30% by weight, based on the total weight of component C), selected from the group consisting of: C6-C 25 - Alkyl alcohol ethoxylates and C6-C 25 - Alkenol ethoxylates, more specifically selected from C8-C 20 -Alkanol ethoxylates and C8-C 20 - Alkenol ethoxylates, especially those selected from C 10 -C 18 - Alkyl alcohol ethoxylates and C 10 -C 18 -Alkenol ethoxylates,

[0241] - At least one second emulsifier of component C4, comprising 3% to 30% by weight, particularly 4% to 25% by weight, and especially 4% to 20% by weight, based on the total weight of component C4, selected from the group consisting of: stilbene phenol ethoxylate, tristilbene phenol ethoxylate, and mixtures thereof, wherein the degree of ethoxylation of component C4 is in the range of 1 to 30, particularly in the range of 5 to 20, and especially in the range of 10 to 18, and

[0242] - At least one C6-C of component C5) comprising 5% to 80% by weight, particularly 10% to 60% by weight, and especially 20% to 40% by weight, of the total weight of component C). 10 - Fatty acid-C1-C4-alkyl ester, which contains at least 50% by weight of at least one C8-fatty acid-C1-C4-alkyl ester.

[0243] In a specific embodiment, the preparation comprises:

[0244] -4% to 11% by weight of benzosulfuron (component A) based on the total weight of the formulation.

[0245] - 0% to 1.5% acetic acid (component B) by weight based on the total weight of the preparation;

[0246] - 0.1% to 2.5% water (component C1) by weight based on the total weight of the preparation.

[0247] - 25% to 50% by weight, preferably 28% to 45% by weight, of the total weight of the preparation (component C2).

[0248] -Based on the total weight of the formulation, 5% to 30% by weight of one or more alcohol ethoxylates selected from the following: C 10 -C 18 -Alkanol ethoxylates, C 10 -C 18 - Alkenol ethoxylates and mixtures thereof, wherein the degree of ethoxylation of these alkenol ethoxylates and alkenol ethoxylates is in the range of 1 to 10, preferably in the range of 2 to 10, for example in the range of 3 to 10; particularly in the range of 2 to 7, particularly in the range of 3 to 5 (component C3).

[0249] -4%-20% by weight of stilbene phenol ethoxylate, tristilbene phenol ethoxylate, or mixtures thereof, each having a degree of ethoxylation in the range of 1 to 30, particularly in the range of 5 to 20, particularly in the range of 10 to 18; preferably 4%-20% by weight of tristilbene phenol ethoxylate (component C4) having a degree of ethoxylation in the range of 1 to 30, particularly in the range of 5 to 20, particularly in the range of 10 to 18; and

[0250] - 20% to 35% by weight of methylated vegetable oil, preferably selected from methylated rapeseed oil, methylated sunflower oil, methylated soybean oil, methylated peanut oil, methylated olive oil, methylated corn oil, methylated grapeseed oil, methylated safflower oil, methylated sesame oil, methylated mangrove fruit oil, methylated low-erucic acid rapeseed oil, methylated hemp seed oil, and mixtures thereof; or at least one saturated C6-C 10 - Fatty acid methyl esters, which preferably contain all C6-C 10 - At least 50% by weight of fatty acid methyl esters of methyl octanoate (component C5).

[0251] More specifically, the preparation comprises:

[0252] -4% to 11% by weight of benzosulfuron (component A) based on the total weight of the formulation.

[0253] - 0% to 1.5% acetic acid (component B) by weight based on the total weight of the preparation;

[0254] - 0.1% to 2.5% water (component C1) by weight based on the total weight of the preparation.

[0255] - DMSO (component C2) at a weight of 28% to 45% based on the total weight of the preparation.

[0256] -Based on the total weight of the formulation, 5% to 30% by weight of one or more alcohol ethoxylates selected from the following: C 10 -C 18 -Alkanol ethoxylates, C 10 -C 18 - Alkenol ethoxylates and mixtures thereof, wherein the degree of ethoxylation of these alkenol ethoxylates and alkenol ethoxylates is in the range of 1 to 10, preferably in the range of 2 to 10, for example in the range of 3 to 10; particularly in the range of 2 to 7, particularly in the range of 3 to 5 (component C3).

[0257] -4%-20% by weight of tristyrylphenol ethoxylate (component C4) having an ethoxylation degree in the range of 10 to 18; and

[0258] - 20% to 35% by weight of methylated rapeseed oil or methyl octanoate, preferably 20% to 30% by weight of methylated rapeseed oil.

[0259] The liquid formulation according to the invention may also contain a water-soluble agrochemically active substance, particularly in the form of a salt, as component D. One preferred water-soluble agrochemically active substance is a water-soluble herbicide.

[0260] More preferably, the water-soluble agrochemical active substance to be used in the liquid formulation according to the present invention is a water-soluble herbicide selected from glufosinate or its salts, dicamba or its salts, glyphosate or its salts, or any derivative or salt of imidazolinone herbicides.

[0261] In a preferred embodiment, the active substance and / or active salt suitable for formulation in the liquid phase of the liquid formulation according to the invention are glufosinate salts, particularly glufosinate-ammonium, and especially L-enantiomer salts, such as L-glufosinate-ammonium. Suitable salts of glyphosate are, for example, glyphosate-ammonium, glyphosate-diammonium, glyphosate-dimethylammonium, glyphosate-isopropylammonium, glyphosate-potassium, glyphosate-sodium, glyphosate-trimethylsulfur, and ethanolamine and diethanolamine salts, preferably glyphosate-diammonium, glyphosate-isopropylammonium, and glyphosate-trimethylsulfur (glufosinate).

[0262] In addition to components A, B, C, and D mentioned above, the formulations of this invention may also contain conventional additives, which are typically included in liquid formulations of organic biocidal compounds. These additives include, but are not limited to, defoamers, dyes, pigments, and preservatives to prevent microbial spoilage. The total amount of these additives will generally not exceed 5% by weight.

[0263] Suitable defoamers for formulations according to the invention are, for example, silicone emulsions (such as Silicone SRE-PFL from Wacker or Rhodorsil from Bluestar Silicones). ® ( ), long-chain alcohols, fatty acids, organofluorine compounds, and mixtures thereof. The amount of such defoamer may depend on the type of defoamer and (if present) is typically in the range of 0.01 wt.-% to 0.5 wt.-% based on the total weight of the formulation.

[0264] Suitable preservatives for preventing microbial spoilage of the compositions of the present invention include formaldehyde, alkyl esters of p-hydroxybenzoic acid, sodium benzoate, 2-bromo-2-nitropropane-1,3-diol, o-phenylphenol, thiazolinones (such as 1,2-benzisothiazol-3(2H)-one, 5-chloro-2-methyl-4-isothiazolinone (CIT), methylisothiazolinone (MIT)), pentachlorophenol, 2,4-dichlorobenzyl alcohol, and mixtures thereof. Commercially available isothiazolone-based preservatives include, for example, those marketed under the trademark Proxel. ® (Arch Chemical) , Acticide ® Grades (such as MV, MBS, and B20) (Thor Chemie) and Kathon ® Sold by MK (Rohm & Haas). 2-Bromo-2-nitropropane-1,3-diol is used as an active agent. ® The L30 is available for commercial purchase.

[0265] The formulation of the present invention can be simply prepared by mixing components A), B) (if present), C), and D) to obtain a solution of component A in a mixture of components B) (if present), C), and D). For example, it is possible to first dissolve component A) in component C) or solvent C.1, and then mix the remaining components with the solution.

[0266] The formulations of this invention are suitable for controlling unwanted plant growth, particularly unwanted plant growth in crops. For this purpose, the aqueous formulation is applied to the unwanted plant or the area in which the unwanted plant will grow.

[0267] The formulations of this invention can be applied to many crops. Crops particularly include field corn, including field corn grown for the production of cereals, seeds, or silage, popcorn, sweet corn, soybeans, chickpeas, edible peas, field peas, lentils (including green and red types), perennial grasses (especially when grown for seed production), and alfalfa (particularly in established dormant alfalfa stands, and in cover crops for cereals, legumes, and oilseeds). These formulations are active against broadleaf and grassy weeds without causing substantial damage to the crop plants. Therefore, the formulations and combinations of this invention are preferably applied pre-emergence, i.e., before the unwanted plants emerge. Pre-emergence application in crops can be carried out shortly before or shortly after crop planting, but is preferably carried out before the crop plants emerge.

[0268] The formulations of this invention can also be applied to crops that have been modified by mutagenesis or genetic engineering to provide new traits to plants or to modify existing traits. Mutagenesis includes random mutagenesis using X-rays or mutagenic chemicals, but also targeted mutagenesis to induce mutations at specific loci in the plant genome. Targeted mutagenesis often uses oligonucleotides or proteins like CRISPR / Cas, zinc finger nucleases, TALENs, or broad-spectrum nucleases to achieve a targeted effect. Genetic engineering typically uses recombinant DNA technology to produce modifications in the plant genome that are not readily available in nature through hybridization, mutagenesis, or natural recombination. Typically, one or more genes are integrated into the plant genome to increase or improve traits. These integrated genes are also referred to in the art as transgenes, and plants containing such transgenes are called transgenic plants. Plant transformation processes typically produce several transformation events, which differ at the genomic loci in which the transgene has been integrated. Plants containing a specific transgene at a specific genomic locus are often described as containing a specific “event,” which is indicated by the name of the specific event. Traits that have been introduced into plants or modified include herbicide tolerance, insect resistance, increased yield, and tolerance to abiotic conditions such as drought.

[0269] Examples of genetically modified crops that can use formulations and combinations include, in particular, maize and soybean: transgenic soybeans containing herbicide tolerance genes are examples, but not excluded, such as GTS 40-3-2, MON87705, MON87708, MON87712, MON87769, MON89788, A2704-12, A2704-21, A5547-127, A5547-35, DP356043, DAS44406-6, DAS68416-4, DAS-81419-2, GU262, SYHTØH2, W62, W98, FG72, and CV127.

[0270] Transgenic cotton containing herbicide tolerance genes include, for example, but not excluding others, 19-51a, 31707, 42317, 81910, 281-24-236, 3006-210-23, BXN10211, BXN10215, BXN10222, BXN10224, MON1445, MON1698, MON88701, MON88913, GHB119, GHB614, LLCotton25, T303-3, and T304-40.

[0271] The formulation of this invention provides excellent vegetation control during the fallow period (i.e., the period after harvest and before the next crop is planted).

[0272] The formulation of this invention also provides excellent vegetation control in non-crop areas, especially at high application rates.

[0273] The formulations of the present invention provide excellent control over the following plants, including

[0274] Broadleaf weeds, such as Amaranth (Amaranthus palmeri), Amaranth (Amaranthus powellii), Galium aparine, Bidens pilosa, Desmodium tortuosum, Bindweed, Polygonum convolvulus, Solanum rostratum, and C. burcucumber. angulatus), all types of free-growing canola (S. canola volunteer) (Brassica spp. species of Brassica spp. of the Brassicaceae family), carpetweed (Mollugo verticillata), mayweed (Chamomile mayweed) (Anthemis cotula), chickweed (Stellaria media), cocklebur (Xanthium strumarium), copperleaf (Acalypha virginica), free-growing cotton (Gossypium hirsutum), cowpea (Vaccaria pyramidata), dandelion (Taraxacum) (officinale), Devil's-claw (Proboscidea Louisiana), Eclipta (Eclipta prostrata), Evening primrose (Eveningprimrose)cutleaf (Oenothera laciniata), small-flowered hyssop (Galinsoga parviflora), small-fruited flax (Camelinamacrocarpa), red-stemmed celery-leaved sunflower (Erodium cicutarium), hairy fleabane (Conyza bonariensis), flixweed (Descurainia sophia), groundcherry (Physalis angulate), groundsel (Senecio vulgaris), narrowleaf (Crepis) tectorum), Hemlock (poison), Conium maculatum, Henbit (Lamium amplexicaule), Horseweed (marestail), Conyza canadensis, Jimsonweed (Datura stramonium), Knotweed (prostrate), Kochia (Kochia scoparia), Ladysthumb (Polygonum persicaria), Lamb's quarters (common), Lamb's quarters (narrowleaf), Lettuce prickly (wild lettuce (Lactuca serriola)), mallow (common) (round-leaved mallow (Malva neglecta)), small-flowered mallow (Mallow,little (cheeseweed) (Malvaparviflora) (Mallow, Venice) (Hibiscus trionum) (Conyza canadensis) (Ipomoea hederacea var. integriuscula) (Ipomoea hederacea var. integriuscula) (Ipomoea hederacea) (Ipomoea hederacea) (Ipomoea wrightii) (Ipomoea wrightii) (Ipomoea alacunose) (Ipomoea purpurea) (Ipomoea purpurea) (Mustard, black) (Brassica) nigra), Mustard (Sisymbrium altissimum), Wild Mustard (Sinapis arvensis), Nettle (Urtica urens), Black Nightshade (Solanum nigrum), Cutleaf Nightshade (Solanum triflorum), Eastern Black Nightshade (Solanum ptycanthum), Hairy Nightshade (Solanum sarrachoides), Parthenium (Parthenium hysterophorus), Field Pennycress (Thlaspi arvense), White Amaranth (Pigweed) Prostrate (Amaranthus blitoides), Pigweed (redroot) (Amaranthus retroflexus), Green-spike amaranth (Pigweed,Smooth (Amaranthus hybridus), creeping pigweed (Amaranthus albus), Puncturevine (Tribulus terrestris), Purslane (Portulaca oleracea), Florida purslane (Richardiascabra), Ragweed (Ambrosia artemisiifolia), Giant Ragweed (Ambrosia trifida), London garlic mustard (Sisymbrium irio), Sesbania (hemp) exaltata), Shepherds-purse (Capsella bursa-pastoris), Sida prickly (Sida spinosa), Smartweed (Polygonum pensylvanicum), annual sowthistle (Sonchus arvensis), nodding spurge (Chamaesyce nutans), spotted spurge (Chamaesyce maculate), bristly starbur (Acanthospermum hispidum), common sunflower (Helianthus annuus), Tansymustard pinnate (Descurainia pinnata), Texas weed (Caperonia palustris), Canadian thistle (Cirsium arvense), Russian thistle (Thistle, Canada)Russian (Salsola kali), Abutilon theophrasti, Amaranthus tuberculatus, and Epilobium adenocaulon;

[0275] Annual grass weeds, such as hare barley (Hordeum murinumspp. leporinum); barnyardgrass (Echinochloa crus-galli); annual bluegrass (Poa annua); roughstalked bluegrass (Poa trivialis); California brome (Bromus carinatus); downy brome (Bromus tectorum); Japanese brome (Bromus japonicus); canarygrass (Phalaris canariensis); and brome (Bromus ryegrass). secalinus), Crabgrass (large) (Digitaria sanguinalis), Crabgrass (smooth) (Digitaria ischaemum), Crowfootgrass (Dactyloctenium aegyptium), Cupgrass (Southwestern) (Eriochloa gracilis), Cupgrass (woolly) (Eriochloa villosa), Fescue (rattail) (Vulpia myuros), Foxtail (giant) (Setaria faberi), Foxtail (green) (Setaria viridis), Foxtail (yellow) (Setaria faberi) pumila), goosegrass (Eleusine indica), Johnsongrass (seedlings), Sorghum halepense, Texas mulberry (Urochloa texana), wild millet (Millet,Wild proso (Panicum miliaceum) , Wild oat (Avena fatua) , Panicum fall (Panicum dichotomiflorum) , Panicum, Texas (Panicum texanum) , Red rice (Oryza sativa) , Italian ryegrass (Lolium multiflorum) , Rigid ryegrass (Lolium rigidum) , Sandbur (Cenchrus spp.) , Shattercane (Sorghum bicolor) , Signalgrass (Brachiaria) The following grasses are listed: platyphylla (Platiphylla), witchgrass (Panicum capillare), flatsedge (Cyperus iria), and nutsedge (Cyperus esculentus).

[0276] The application of the formulation of the present invention can vary according to the ratio, which can depend on the type of ground on which the formulation is applied, typically in the range of 0.02 to 1.5 kg / ha, and particularly in the range of 0.03 to 1 kg / ha.

[0277] The application rate of PPO inhibitors is typically in the range of 10 to 300 g / ha, particularly in the range of 15 to 200 g / ha.

[0278] The formulations of this invention can be applied before planting, before emergence, or as a non-selective application, particularly in autumn. Pre-planting application can be done by surface application or by incorporating the formulation or a combination of individual herbicides into the ground.

[0279] Pre-planting surface application is typically carried out by uniformly broadcasting the herbicide onto the soil surface. Pre-planting surface application is usually performed within 30 days of planting and before crop emergence. For pre-planting incorporation (PPI) application, the formulation or combination of herbicides is typically incorporated into the soil surface, for example, to a depth of 2 to 6 cm, preferably within 14 days of planting. Incorporation can be performed by shallow incorporation, including with field tillers, harrows, rotary tillers, or finishing discs.

[0280] The application of the formulation of the present invention can be carried out using water or liquid nitrogen fertilizer as a spraying carrier. For this purpose, the corresponding formulation is diluted with water or liquid nitrogen fertilizer to obtain a liquid spray solution. Typically, the amount of water used is at least 20 L / ha, particularly at least 25 L / ha, and can be as high as 1000 L / ha.

[0281] The spray solution can be applied in a conventional manner using techniques familiar to a skilled technician. Suitable techniques include spraying, atomizing, dusting, spreading, or watering. The type of application depends on the intended purpose, and in any case, they should ensure the finest possible distribution of the active ingredients according to the invention.

[0282] It is also possible to apply the formulation of the present invention in the form of fertilizer granules, which have been impregnated with the formulation of the present invention.

[0283] To achieve a broader spectrum of activity, it is possible to co-apply the formulations of this invention with other herbicides.

[0284] The formulations of the present invention can be administered together with adjuvants that act as modifiers. Particularly preferred adjuvants are described in WO 00 / 53014 and WO2010 / 037734. These adjuvants are C5-C. 22 -Alkyl esters of alkyl acids C1-C5, C 10 -C 20 A combination of a carboxylic acid, a partially phosphate or sulfated polyalkyl ether with monohydroxy functionalization, and an alkyl polyoxyethylene polyether. Preferred C5-C. 22 - Alkyl esters of alkyl oleates (C1-C5-alkyl esters) are methyl oleate, methyl palmitate, and ethyl oleate, and mixtures thereof. Specifically, C5-C... 22 - Alkyl esters of alkyl oleates contain at least 70% by weight methyl oleate or a mixture of methyl oleate and methyl palmitate. Such action modifier systems are commercially available under the name DASH®, such as DASH® HC, from BASF Corporation, USA. Other action modifiers include, but are not limited to, those adjuvants commonly used in combination with glyphosate, such as nonionic surfactants (NIS), ammonium sulfate, C... 6-18 Alkyl sulfates of alkanols, such as sodium dodecyl sulfate, C6-18 Alkyl ether sulfates of alkanols, methylated soybean oil (MSO), and crop oil concentrate (COC).

[0285] The following examples are intended to further illustrate the invention, but are not intended to limit its scope in any way.

[0286] The invention will be described in more detail by way of examples below. Example

[0287] Preparation of liquid formulations

[0288] Use the following ingredients:

[0289] Emulsifier C3a: Oleyl alcohol ethoxylate (Emulsogen M; Clariant International Ltd)

[0290] Emulsifier C3b: Lutensol TO5 (BASF SE) – Isotridecyl alcohol ethoxylate

[0291] Emulsifier C3c:C 10 -C 18 Alkyl alcohol ethoxylates (ethoxylated with 5 EO) (Lutensol M5, BASF)

[0292] Emulsifier C4a: Tristyrylphenol ethoxylate (Soprophor BSU; Solvay SA)

[0293] Component C5a: Methylated rapeseed oil (Agnique ME 18 RD-F; BASF AG)

[0294] Component C5b: Methyl octanoate (Agnique ME 890)

[0295] The liquid preparations of Examples 1 to 8 of the present invention are prepared according to the following procedures:

[0296] Pour DMSO into a container, add bensulfuron-methyl and mix until the bensulfuron-methyl dissolves. Then add the emulsifier and all other ingredients in the required amounts and mix until homogeneous.

[0297] Table 1: Examples of formulations containing component B, 1 to 5

[0298]

[0299] Based on the weight ratio of the total weight of the preparations

[0300] Table 2: Examples of formulations 6 to 8 that do not contain component B

[0301]

[0302] Based on the weight ratio of the total weight of the preparations

[0303] Analytical methods

[0304] 1.1 Particle size

[0305] The average particle size of particles in liquid formulations can also be determined using Malvern HPPS via dynamic light scattering (DLS) as described above.

[0306] 1.2 Light transmittance

[0307] The transmittance (LD100 value) of liquid formulations was determined by measuring the transmitted light intensity at 525 nm and a 1 cm cuvette using a DR 6000 photometer (Hach Lange) with the corresponding polymer dispersion “as is” (i.e., in its undiluted form). The light diffusion factor (LD100 value as a percentage) describes how much light passes through the sample at a given cuvette length relative to pure water, which exhibits an LD100 value of 100.

[0308] 1.3 Degradation of Component A (Phenyrimazole)

[0309] The degradation of pyrimisulfuron was determined by ultra-high pressure liquid chromatography (UPLC).

[0310] 1.4 Dilution stability of liquid formulations

[0311] Dilution stability was determined using CIPAC MT 36.3 testing.

[0312] 1.5 viscosity

[0313] Tested using CIPAC MT 192 (rotational viscosity determination); shear rate 100 s⁻¹ -1 To measure viscosity.

[0314] result

[0315] Based on visual inspection, the liquid preparations in Examples 1 to 8 are homogeneous liquids at room temperature.

[0316] In the cases of the formulations in Examples 1 and 2, uniformity at room temperature was further confirmed by measuring particle size and transmittance.

[0317] After storage at +54°C for 2 weeks or at 80°C for 8 weeks, the degradation of benzosulfuron in each liquid formulation of Examples 1 to 8 was less than 1%.

[0318] In the case of the formulations in Examples 1 and 2, after storage at +54°C for 2 weeks, a 1% dilution in deionized water was prepared, producing a stable, turbid spray dispersion for several hours.

[0319] Additional results are compiled in the following stability test section.

[0320] Stability test

[0321] The stability of several representative formulations was investigated according to industry-standard tests from the CIPAC method (conical cylinder test according to CIPAC MT 36.3). In addition, some formulations were kept at 54°C for 2 weeks (2w 54°C) and at 40°C for 8 weeks (8w 40°C). To investigate storage stability over time, properties were determined immediately after composition preparation and immediately after storage.

[0322] The degree of uniformity and the formation of slurry and sediment were evaluated by visual inspection.

[0323] The results are compiled in Table 3.

[0324] Table 3

[0325]

[0326] nd not determined

[0327] Bs sediments

[0328] Sp Bs trace sediments

[0329] R slurry

[0330] Self-emulsification (after 3 shakes)

[0331] TS partially self-emulsifies (after 3 shakes)

[0332] As can be seen, the tested formulations remained stable over time, even under more severe conditions. Generally, the formation of up to 2 ml of sediment is considered acceptable. The tested formulations showed significantly less sediment formation. The viscosity of the tested formulations remained essentially constant. pH variations were within acceptable limits.

Claims

1. A liquid agricultural preparation containing a) At least one herbicide belonging to the group consisting of PPO inhibitors as component A), b) Optionally, at least one organic acid having a pKA value in the range of 1 to 6, particularly in the range of 3 to 5, as component B), and c) The solvent-emulsifier combination as component C), which contains c1) Water as component C1), c2) is at least one water-miscible organic solvent as component C2). c3) is at least one first emulsifier of component C3), selected from the group consisting of: C6-C 25 -Alkyl alcohol alkoxylates, C6-C 25 - Alkenol alkoxylates and mixtures thereof c4) is at least one second emulsifier as component C4), selected from the group consisting of arylphenol ethoxylates and mixtures thereof, and c5) as at least one C6-C of component C5) 20 -Fatty acid-C1-C4-alkyl esters, especially at least one C6-C4 alkyl ester 20 - Fatty acid methyl esters or ethyl esters.

2. The formulation according to claim 1, wherein, Component A) is pyrimethanil and / or trifluralin.

3. The formulation according to claim 1, wherein, Component A) is pyrimethanil.

4. The preparation according to any one of the preceding claims, wherein, Component B) is a C1-C4-alkanoic acid.

5. The formulation according to claim 4, wherein, Component B) is acetic acid.

6. The preparation according to any one of the preceding claims, comprising: If component B is present: -Based on the total weight of the preparation, component A accounts for 1% to 30% by weight, and particularly 4% to 25% by weight. -Based on the total weight of the preparation, 0.01% to 5% by weight, particularly 0.03% to 4% by weight of component B), and -Based on the total weight of the preparation, component C accounts for 65% to 98.99% by weight, particularly 71% to 95.97% by weight; and If component B) is not present: -Based on the total weight of the preparation, component A accounts for 1% to 30% by weight, particularly 4% to 25% by weight, and -Based on the total weight of the preparation, component C accounts for 70% to 99% by weight, particularly 75% to 96% by weight.

7. The preparation according to any one of the preceding claims, wherein, One, two, or all three of the following conditions a), b), and / or c) apply: a) In each case, based on the total weight of component C), component C) comprises, - Components C1) and C2) in total weight ranging from 10% to 85%, preferably from 20% to 60%, and more preferably from 20% to 50% by weight. - Components C3) and C4) in total weight ranging from 5% to 85%, preferably from 10% to 50%, and more preferably from 10% to 40% by weight. - Component C5, in total amount ranging from 5% to 80% by weight, preferably from 10% to 60% by weight, and more preferably from 20% to 40% by weight; and / or b) The relative amounts of these components C1) and C2) are as follows: -Based on the total weight of these components C1) and C2), 0.5% to 20% by weight, preferably 1% to 10% by weight of component C1), and -Based on the total weight of these components C1) and C2) 80% to 99.5% by weight, preferably 90% to 99% by weight of component C2); and / or c) The relative amounts of these components C3) and C4) are as follows: -Based on the total weight of these components C3) and C4) 30% to 90% by weight, preferably 35% to 90% by weight of component C3), and -Based on the total weight of these components C3) and C4) 10% to 70%, preferably 10% to 65% of component C4 by weight).

8. The preparation according to any one of the preceding claims, wherein, The component C2) is selected from the group consisting of: 1-methoxy-2-propyl acetate, C1-C4-alkyl lactate, C1-C4-alkyl lactamide, di-(C1-C2-alkyl) lactamide, N-C1-C4-alkyl-2-pyrrolidone, ε-caprolactam, C4-C6 lactone, C2-C4-alkylene carbonate, dimethyl sulfoxide, N,N-dimethylimidazoline-2-one, and mixtures thereof.

9. The formulation according to claim 8, wherein, The component C2) contains or is composed of dimethyl sulfoxide.

10. The preparation according to any one of the preceding claims, wherein, This component (C3) is selected from the group consisting of: C8-C 20 -Alkanols-C2-C4-alkoxylates and C8-C 20 - Alkenol-C2-C4-alkoxylates and mixtures thereof, wherein the degree of alkoxylation is in the range of 1 to 10, particularly in the range of 2 to 7, particularly in the range of 3 to 5; Preferably, this C8-C 20 -Alkanols-C2-C4-alkoxylates and C8-C 20 -Alkenol-C2-C4-alkoxylates are ethoxylates or ethoxylate-co-propoxylates.

11. The preparation according to any one of the preceding claims, wherein, The component C4) is selected from the group consisting of stilbene phenol ethoxylate, tristilbene phenol ethoxylate and mixtures thereof, and preferably selected from tristilbene phenol ethoxylate.

12. The preparation according to any one of the preceding claims, wherein, The degree of ethoxylation of the component (C4) is in the range of 1 to 30, particularly in the range of 5 to 20, and particularly in the range of 10 to 18.

13. The preparation according to any one of the preceding claims, wherein, This component (C5) contains at least one unsaturated C 18 -Fatty acid-C1-C4-alkyl ester; Preferably, component C5) comprises at least 60% by weight of the at least one unsaturated C based on the total weight of component C5). 18 -Fatty acid-C1-C4-alkyl esters, Specifically, component C5) includes the total weight based on component C5). -C not exceeding 21% by weight 10 -C 17 -Fatty acid-C1-C4-alkyl esters, -C not exceeding 2% by weight 19 -C 20 -Fatty acid-C1-C4-alkyl esters, - No more than 8% by weight of C1-C4 alkyl palmitic acid esters, and - Stearic acid C1-C4-alkyl esters not exceeding 4% by weight.

14. The preparation according to any one of the preceding claims, wherein, The component C5) is a methylated vegetable oil or a mixture of methylated vegetable oils, particularly selected from the group consisting of: methylated rapeseed oil, methylated sunflower oil, methylated soybean oil, methylated peanut oil, methylated olive oil, methylated corn oil, methylated grapeseed oil, methylated safflower oil, methylated sesame oil, methylated manure palm fruit oil, methylated low-erucic acid rapeseed oil, and methylated hemp seed oil; and specifically, methylated rapeseed oil.

15. The preparation according to any one of claims 1 to 12, wherein, This component (C5) contains C6-C. 10 - Fatty acid methyl esters or those composed of them.

16. The preparation according to any one of the preceding claims, comprising: -4% to 11% by weight of benzosulfuron (component A) based on the total weight of the formulation. - 0% to 1.5% acetic acid (component B) by weight based on the total weight of the preparation; - 0.1% to 2.5% water (component C1) by weight based on the total weight of the preparation. - 25% to 50% by weight, preferably 28% to 45% by weight, of the total weight of the preparation (component C2). -Based on the total weight of the formulation, 5% to 30% by weight of one or more alcohol ethoxylates selected from the following: C 10 -C 18 -Alkanol ethoxylates, C 10 -C 18 - Alkenol ethoxylates and mixtures thereof, wherein the degree of ethoxylation of these alkenol ethoxylates and alkenol ethoxylates is in the range of 1 to 10, preferably in the range of 2 to 10, for example in the range of 3 to 10; more preferably in the range of 2 to 7, especially in the range of 3 to 5 (component C3). -4%-20% by weight of stilbene phenol ethoxylate, tristilbene phenol ethoxylate, or mixtures thereof, each having a degree of ethoxylation in the range of 1 to 30, particularly in the range of 5 to 20, particularly in the range of 10 to 18; preferably 4%-20% by weight of tristilbene phenol ethoxylate (component C4) having a degree of ethoxylation in the range of 1 to 30, particularly in the range of 5 to 20, particularly in the range of 10 to 18; and - 20% to 35% by weight of methylated vegetable oil or mixtures of methylated vegetable oils, wherein the methylated vegetable oil is preferably selected from the group consisting of: methylated rapeseed oil, methylated sunflower oil, methylated soybean oil, methylated peanut oil, methylated olive oil, methylated corn oil, methylated grapeseed oil, methylated safflower oil, methylated sesame oil, methylated manure palm fruit oil, methylated low erucic acid rapeseed oil, methylated hemp seed oil, and mixtures thereof; or At least one saturated C6-C by weight, at 20% to 35% 10 - Fatty acid methyl esters, which preferably contain all C6-C 10 - At least 50% by weight of fatty acid methyl esters of methyl octanoate (component C5).

17. The preparation according to claim 16, comprising: -4% to 11% by weight of benzosulfuron (component A) based on the total weight of the formulation. - 0% to 1.5% acetic acid (component B) by weight based on the total weight of the preparation; - 0.1% to 2.5% water (component C1) by weight based on the total weight of the preparation. - DMSO (component C2) at a weight of 28% to 45% based on the total weight of the preparation. -Based on the total weight of the formulation, 5% to 30% by weight of one or more alcohol ethoxylates selected from the following: C 10 -C 18 -Alkanol ethoxylates, C 10 -C 18 - Alkenol ethoxylates and mixtures thereof, wherein the degree of ethoxylation of these alkenol ethoxylates and alkenol ethoxylates is in the range of 1 to 10, preferably in the range of 2 to 10, for example in the range of 3 to 10; more preferably in the range of 2 to 7, especially in the range of 3 to 5 (component C3). -4%-20% by weight of tristyrylphenol ethoxylate (component C4) having an ethoxylation degree in the range of 10 to 18; and - 20% to 35% by weight of methylated rapeseed oil or methyl octanoate; preferably 20% to 30% by weight of methylated rapeseed oil.

18. A method for preparing a liquid formulation according to any one of the preceding claims, the method comprising mixing the components A), C) and optionally B).

19. Use of the liquid formulation according to any one of claims 1 to 17 for controlling the growth of unwanted plants.

20. A method for controlling the growth of unwanted plants, the method comprising the step of applying a preparation according to any one of claims 1 to 17 to the unwanted plants, to portions of the unwanted plants, or to areas where the unwanted plants grow or may grow.

Citation Information

Patent Citations

  • Herbicidal mixture containing a 3-heterocyclyl-substituted benzoyl derivative and an adjuvant

    WO2000053014A1

  • Composition for improving the efficacy of herbicides

    WO2010037734A2

  • Aqueous suspension concentrate formulations containing saflufenacil

    WO2011023759A2

  • Liquid suspension concentrate formulations containing saflufenacil

    WO2011070051A2

  • Novel soluble liquid compositions of saflufenacil, method of preparation and use thereof

    WO2021038439A1